{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:01:16Z","timestamp":1784134876580,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.mehy.2016.12.003","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T09:16:05Z","timestamp":1481706965000},"page":"15-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Cannabinoids: Possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation"],"prefix":"10.1016","volume":"99","author":[{"given":"Amir Hossein","family":"Norooznezhad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Norooznezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mehy.2016.12.003_b0005","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.autrev.2014.11.012","article-title":"T cell responses in psoriasis and psoriatic arthritis","volume":"14","author":"Diani","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"5 Suppl 93","key":"10.1016\/j.mehy.2016.12.003_b0010","first-page":"20","article-title":"The joint in psoriatic arthritis","volume":"33","author":"Mortezavi","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"9583","key":"10.1016\/j.mehy.2016.12.003_b0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"The Lancet"},{"issue":"7130","key":"10.1016\/j.mehy.2016.12.003_b0020","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mehy.2016.12.003_b0025","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.rdc.2015.07.013","article-title":"Etiology and pathogenesis of psoriasis","volume":"41","author":"Boehncke","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.mehy.2016.12.003_b0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1358\/dnp.2008.21.2.1188196","article-title":"Angiogenesis: the new potential target for the therapy of psoriasis","volume":"21","author":"Heidenreich","year":"2008","journal-title":"Drug News Perspect"},{"issue":"6","key":"10.1016\/j.mehy.2016.12.003_b0035","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.mehy.2014.03.007","article-title":"Next target of tranilast: inhibition of corneal neovascularization","volume":"82","author":"Norooznezhad","year":"2014","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2016.12.003_b0040","first-page":"3","article-title":"Medical hypotheses and ideas","volume":"4","author":"Keshavarz","year":"2010","journal-title":"Irn J Med Hypotheses Ideas"},{"issue":"4","key":"10.1016\/j.mehy.2016.12.003_b0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11926-005-0044-5","article-title":"Angiogenesis in psoriasis and psoriatic arthritis: clues to disease pathogenesis","volume":"7","author":"Leong","year":"2005","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.mehy.2016.12.003_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2011.04.007","article-title":"Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis","volume":"63","author":"Armstrong","year":"2011","journal-title":"J Dermatol Sci"},{"issue":"4","key":"10.1016\/j.mehy.2016.12.003_b0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1024515517623","article-title":"Angiogenesis in psoriasis","volume":"5","author":"Creamer","year":"2002","journal-title":"Angiogenesis"},{"key":"10.1016\/j.mehy.2016.12.003_b0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.reprotox.2016.03.002","article-title":"The endocannabinoid system: a novel player in human placentation","volume":"61","author":"Costa","year":"2016","journal-title":"Reprod Toxicol"},{"issue":"13","key":"10.1016\/j.mehy.2016.12.003_b0065","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1096\/fj.06-7689com","article-title":"Inhibition of human hair follicle growth by endo-and exocannabinoids","volume":"21","author":"Telek","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.mehy.2016.12.003_b0070","series-title":"The emerging role of the endocannabinoid system in cardiovascular disease","author":"Pacher","year":"2009"},{"issue":"5","key":"10.1016\/j.mehy.2016.12.003_b0075","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s11481-013-9485-1","article-title":"Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction","volume":"8","author":"Robinson","year":"2013","journal-title":"J Neuroimmune Pharmacol"},{"issue":"4","key":"10.1016\/j.mehy.2016.12.003_b0080","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.4049\/jimmunol.173.4.2373","article-title":"Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-\u03baB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation","volume":"173","author":"Do","year":"2004","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.mehy.2016.12.003_b0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1468-3083.2004.01184.x","article-title":"Cannabinoids, loratadine and allopurinol as novel additions to the antipsoriatic ammunition","volume":"19","author":"Namazi","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.mehy.2016.12.003_b0090","doi-asserted-by":"crossref","DOI":"10.2174\/1574884711666160511150126","article-title":"Cannabis for refractory psoriasis-high hopes for a novel treatment and a literature review","author":"Derakhshan","year":"2016","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.mehy.2016.12.003_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.med.57.121304.131306","article-title":"Angiogenesis","volume":"57","author":"Folkman","year":"2006","journal-title":"Annu Rev Med"},{"issue":"2","key":"10.1016\/j.mehy.2016.12.003_b0100","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s10147-016-0957-1","article-title":"Tumor angiogenesis\u2014characteristics of tumor endothelial cells","volume":"21","author":"Hida","year":"2016","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"10.1016\/j.mehy.2016.12.003_b0105","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2353\/ajpath.2008.080088","article-title":"Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis","volume":"173","author":"Elias","year":"2008","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.mehy.2016.12.003_b0110","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2613.2009.00669.x","article-title":"Angiogenesis drives psoriasis pathogenesis","volume":"90","author":"Heidenreich","year":"2009","journal-title":"Int J Exp Pathol"},{"issue":"4","key":"10.1016\/j.mehy.2016.12.003_b0115","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/039463200601900405","article-title":"VEGF is likely a key factor in the link between inflammation and angiogenesis in psoriasis: results of an immunohistochemical study","volume":"19","author":"Simonetti","year":"2006","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.mehy.2016.12.003_b0120","article-title":"HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies","volume":"1\u201317","author":"Subhani","year":"2016","journal-title":"Angiogenesis"},{"issue":"7181","key":"10.1016\/j.mehy.2016.12.003_b0125","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/nature06613","article-title":"HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1&agr","volume":"451","author":"Arany","year":"2008","journal-title":"Nature"},{"issue":"3\u20134","key":"10.1016\/j.mehy.2016.12.003_b0130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/10273360410001700843","article-title":"Tumour-induced angiogenesis: a review: review article","volume":"5","author":"Plank","year":"2003","journal-title":"J Theor Med"},{"issue":"1","key":"10.1016\/j.mehy.2016.12.003_b0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.0022-202X.2003.22107.x","article-title":"Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset","volume":"122","author":"Young","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.mehy.2016.12.003_b0140","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.180.3.1141","article-title":"Overexpression of vascular permeability factor\/vascular endothelial growth factor and its receptors in psoriasis","volume":"180","author":"Detmar","year":"1994","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.mehy.2016.12.003_b0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1517\/13543784.2012.636351","article-title":"Investigational VEGF antagonists for psoriasis","volume":"21","author":"Crawshaw","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"10.1016\/j.mehy.2016.12.003_b0150","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1046\/j.1365-2133.1999.03205.x","article-title":"Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis","volume":"141","author":"Bhushan","year":"1999","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.mehy.2016.12.003_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2014.01.068","article-title":"Matrix metalloproteinases and their role in psoriasis","volume":"540","author":"Mezentsev","year":"2014","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.mehy.2016.12.003_b0160","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00403-006-0723-8","article-title":"Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman\u2019s therapy","volume":"298","author":"Andrys","year":"2007","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"10.1016\/j.mehy.2016.12.003_b0165","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1747.2001.01316.x","article-title":"Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis","volume":"116","author":"Kuroda","year":"2001","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.mehy.2016.12.003_b0170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nm1351","article-title":"Angiopoietin-2 sensitizes endothelial cells to TNF-\u03b1 and has a crucial role in the induction of inflammation","volume":"12","author":"Fiedler","year":"2006","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.mehy.2016.12.003_b0175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nm804","article-title":"Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease","volume":"9","author":"Ghoreschi","year":"2003","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.mehy.2016.12.003_b0180","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.clindermatol.2007.08.012","article-title":"Immunopathogenesis and role of T cells in psoriasis","volume":"25","author":"Ghoreschi","year":"2007","journal-title":"Clin Dermatol"},{"issue":"7","key":"10.1016\/j.mehy.2016.12.003_b0185","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1128\/MCB.17.7.4015","article-title":"Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis","volume":"17","author":"Yoshida","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.mehy.2016.12.003_b0190","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/1523-1747.ep12616634","article-title":"Interleukin-8 stimulates calcium transients and promotes epidermal cell proliferation","volume":"99","author":"Tuschil","year":"1992","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.mehy.2016.12.003_b0195","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.4049\/jimmunol.170.6.3369","article-title":"IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis","volume":"170","author":"Li","year":"2003","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.mehy.2016.12.003_b0200","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.4049\/jimmunol.151.8.4399","article-title":"Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro","volume":"151","author":"Schulz","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2016.12.003_b0205","article-title":"The Role of IL-17 in the pathogenesis of psoriasis and update on IL-17 inhibitors for the treatment of plaque psoriasis","author":"Walsh","year":"2016","journal-title":"J Cutan Med Surg."},{"issue":"6","key":"10.1016\/j.mehy.2016.12.003_b0210","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4103\/0019-5154.143574","article-title":"Remission of psoriasis and psoriatic arthritis during bevacizumab therapy for renal cell cancer","volume":"59","author":"Datta-Mitra","year":"2014","journal-title":"Indian J Dermatol"},{"issue":"6","key":"10.1016\/j.mehy.2016.12.003_b0215","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/MAJ.0b013e3181dd1aa5","article-title":"Improvement of psoriasis during sunitinib therapy for renal cell carcinoma","volume":"339","author":"Narayanan","year":"2010","journal-title":"Am J Med Sci"},{"issue":"3","key":"10.1016\/j.mehy.2016.12.003_b0220","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.trsl.2007.01.003","article-title":"SU-011248, a vascular endothelial growth factor receptor-tyrosine kinase inhibitor, controls chronic psoriasis","volume":"149","author":"Keshtgarpour","year":"2007","journal-title":"Transl Res"},{"issue":"1","key":"10.1016\/j.mehy.2016.12.003_b0225","first-page":"115","article-title":"Infliximab for the treatment of plaque psoriasis","volume":"2","author":"Gall","year":"2008","journal-title":"Biologics"},{"issue":"2","key":"10.1016\/j.mehy.2016.12.003_b0230","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s12013-013-9563-2","article-title":"Antiangiogenic effect of methotrexate and PUVA on psoriasis","volume":"67","author":"Shaker","year":"2013","journal-title":"Cell Biochem Biophys"},{"issue":"1","key":"10.1016\/j.mehy.2016.12.003_b0235","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaad.2015.03.041","article-title":"Angiogenesis and lymphangiogenesis in inflammatory skin disorders","volume":"73","author":"Varricchi","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.mehy.2016.12.003_b0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/2322-1232.222592","article-title":"How could cannabinoids be effective in multiple evanescent white dot syndrome? A hypothesis","volume":"5","author":"Norooznezhad","year":"2016","journal-title":"J Rep Pharm Sci"},{"issue":"16","key":"10.1016\/j.mehy.2016.12.003_b0245","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1158\/0008-5472.CAN-03-3927","article-title":"Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas","volume":"64","author":"Bl\u00e1zquez","year":"2004","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.mehy.2016.12.003_b0250","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1158\/0008-5472.CAN-07-5176","article-title":"Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression","volume":"68","author":"Bl\u00e1zquez","year":"2008","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.mehy.2016.12.003_b0255","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1189\/jlb.0307159","article-title":"Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis","volume":"82","author":"Xu","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"4","key":"10.1016\/j.mehy.2016.12.003_b0260","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nm1561","article-title":"Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells","volume":"13","author":"Maresz","year":"2007","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.mehy.2016.12.003_b0265","doi-asserted-by":"crossref","first-page":"e80022","DOI":"10.1371\/journal.pone.0080022","article-title":"The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties","volume":"8","author":"Rossi","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.mehy.2016.12.003_b0270","doi-asserted-by":"crossref","first-page":"H2210","DOI":"10.1152\/ajpheart.00688.2007","article-title":"CB2-receptor stimulation attenuates TNF-\u03b1-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion","volume":"293","author":"Rajesh","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.mehy.2016.12.003_b0275","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.26598","article-title":"Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver","volume":"59","author":"Guillot","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mehy.2016.12.003_b0280","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jdermsci.2006.10.009","article-title":"Cannabinoids inhibit human keratinocyte proliferation through a non-CB1\/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis","volume":"45","author":"Wilkinson","year":"2007","journal-title":"J Dermatol Sci"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716302092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716302092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T05:15:37Z","timestamp":1718946937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987716302092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":56,"alternative-id":["S0306987716302092"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2016.12.003","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoids: Possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2016.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}